US Patent Issued to CALCILYTIX THERAPEUTICS on July 15 for "Formulations of triphenyl calcilytic compounds" (California Inventors)

ALEXANDRIA, Va., July 16 -- United States Patent no. 12,357,576, issued on July 15, was assigned to CALCILYTIX THERAPEUTICS INC. (Palo Alto, Calif.).

"Formulations of triphenyl calcilytic compounds" was invented by Uma Sinha (San Francisco), Ananth Sridhar (San Francisco), Leena Prasad (San Francisco) and Ali Komeyli (San Francisco).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides tablet formulations including a triphenyl calcilytic compound for the treatment of autosomal dominant hypocalcemia (ADH), where the compound is represented by formula (I):a solvate, a hydrate, a pharmaceutically acceptable salt, or a combination thereof."

The patent was filed on June 29, 2023, under Ap...